These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 19061379

  • 1. Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury.
    Cox CD, West EJ, Liu MC, Wang KK, Hayes RL, Lyeth BG.
    J Neurotrauma; 2008 Nov; 25(11):1355-65. PubMed ID: 19061379
    [Abstract] [Full Text] [Related]

  • 2. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
    Pike BR, Flint J, Dutta S, Johnson E, Wang KK, Hayes RL.
    J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
    [Abstract] [Full Text] [Related]

  • 3. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.
    Ringger NC, O'Steen BE, Brabham JG, Silver X, Pineda J, Wang KK, Hayes RL, Papa L.
    J Neurotrauma; 2004 Oct; 21(10):1443-56. PubMed ID: 15672634
    [Abstract] [Full Text] [Related]

  • 4. Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest.
    Weiss ES, Wang KK, Allen JG, Blue ME, Nwakanma LU, Liu MC, Lange MS, Berrong J, Wilson MA, Gott VL, Troncoso JC, Hayes RL, Johnston MV, Baumgartner WA.
    Ann Thorac Surg; 2009 Aug; 88(2):543-50. PubMed ID: 19632410
    [Abstract] [Full Text] [Related]

  • 5. Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury.
    Pike BR, Zhao X, Newcomb JK, Posmantur RM, Wang KK, Hayes RL.
    Neuroreport; 1998 Aug 03; 9(11):2437-42. PubMed ID: 9721910
    [Abstract] [Full Text] [Related]

  • 6. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
    Cardali S, Maugeri R.
    J Neurosurg Sci; 2006 Jun 03; 50(2):25-31. PubMed ID: 16841024
    [Abstract] [Full Text] [Related]

  • 7. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
    Brophy GM, Pineda JA, Papa L, Lewis SB, Valadka AB, Hannay HJ, Heaton SC, Demery JA, Liu MC, Tepas JJ, Gabrielli A, Robicsek S, Wang KK, Robertson CS, Hayes RL.
    J Neurotrauma; 2009 Apr 03; 26(4):471-9. PubMed ID: 19206997
    [Abstract] [Full Text] [Related]

  • 8. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ, Glushakova O, Mondello S, Van K, Hayes RL, Lyeth BG.
    J Neurotrauma; 2015 Aug 15; 32(16):1179-89. PubMed ID: 25763798
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Spectrin breakdown products in the cerebrospinal fluid in severe head injury--preliminary observations.
    Farkas O, Polgár B, Szekeres-Barthó J, Dóczi T, Povlishock JT, Büki A.
    Acta Neurochir (Wien); 2005 Aug 15; 147(8):855-61. PubMed ID: 15924207
    [Abstract] [Full Text] [Related]

  • 12. Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.
    McGinn MJ, Kelley BJ, Akinyi L, Oli MW, Liu MC, Hayes RL, Wang KK, Povlishock JT.
    J Neuropathol Exp Neurol; 2009 Mar 15; 68(3):241-9. PubMed ID: 19225412
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
    Pineda JA, Lewis SB, Valadka AB, Papa L, Hannay HJ, Heaton SC, Demery JA, Liu MC, Aikman JM, Akle V, Brophy GM, Tepas JJ, Wang KK, Robertson CS, Hayes RL.
    J Neurotrauma; 2007 Feb 15; 24(2):354-66. PubMed ID: 17375999
    [Abstract] [Full Text] [Related]

  • 14. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury.
    Kupina NC, Nath R, Bernath EE, Inoue J, Mitsuyoshi A, Yuen PW, Wang KK, Hall ED.
    J Neurotrauma; 2001 Nov 15; 18(11):1229-40. PubMed ID: 11721741
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
    Thompson SN, Gibson TR, Thompson BM, Deng Y, Hall ED.
    Exp Neurol; 2006 Sep 15; 201(1):253-65. PubMed ID: 16814284
    [Abstract] [Full Text] [Related]

  • 17. Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats.
    Lyeth BG, Gong QZ, Shields S, Muizelaar JP, Berman RF.
    Exp Neurol; 2001 May 15; 169(1):191-9. PubMed ID: 11312571
    [Abstract] [Full Text] [Related]

  • 18. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.
    Mondello S, Robicsek SA, Gabrielli A, Brophy GM, Papa L, Tepas J, Robertson C, Buki A, Scharf D, Jixiang M, Akinyi L, Muller U, Wang KK, Hayes RL.
    J Neurotrauma; 2010 Jul 15; 27(7):1203-13. PubMed ID: 20408766
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of M1 muscarinic blockade on behavior and physiological responses following traumatic brain injury in the rat.
    Robinson SE, Foxx SD, Posner MG, Martin RM, Davis TR, Guo HZ, Enters EK.
    Brain Res; 1990 Mar 12; 511(1):141-8. PubMed ID: 2331611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.